Posts by admin
The Growing Global Battle Against Blood-Sucking Ticks
On a balmy day in late June, Scott Williams waits for a white-footed mouse (Peromyscus leucopus) to fall asleep. Williams, a wildlife biologist with the Connecticut Agricultural Experiment Station in New Haven, has just transferred the animal from a trap to a plastic bag containing a cotton ball doused in anaesthetic. As soon as the…
Read MoreDeadly Animal Diseases Can Jump to Humans. Is Vaccinating Wildlife the Answer?
Every January, planes dump one million small plastic packets covered in fishmeal crumbles along the Texas-Mexico border. When the sharp teeth of feral dogs or coyotes pierce the plastic, a liquid rabies vaccine squirts into their mouths. Full article
Read More“Major League” Researcher: Trela worked an internship at US Biologic this summer, holds a 4.0 GPA in biomedical engineering.
As part of his major, the shortstop needed an internship and was eager to complete one close to his second “home.” The senior, through Bumgardner, was connected with Dr. Jolieke van Oosterwijk, Chief Science Officer with an innovative biotech company called US Biologic located in downtown Memphis. The disease prevention company develops oral vaccines to…
Read MoreUSDA and US Biologic, Inc. Announce New Oral Solution to Combat Major Poultry Disease
Researchers at the USDA’s Agricultural Research Service and US Biologic, Inc., have developed an oral solution to an antibiotic alternative that fights against poultry coccidiosis, which costs the poultry industry $3.5B in annual losses worldwide. Full article
Read MoreUS Biologic joins the Securing America’s Medicines and Supply Coalition
“US Biologic envisions a world where everyone has equitable access to lifesaving technologies,” stated Mason Kauffman, CEO of US Biologic. “Our mission is to reduce disease through predictive analytics and orally delivered vaccines and therapeutics delivered to the home. The SAMS Coalition will help impact policy to rebuild American infrastructure and strategic product stockpiles, and…
Read MoreBARDA DRIVe partners with US Biologic, Inc. in the development of an oral vaccine for pandemic influenza
The U.S. DHHS Biomedical Advanced Research and Development Authority (BARDA) Division of Research Innovation and Ventures (DRIVe) is partnering with US Biologic Inc. to advance the development of an oral vaccine for the influenza virus. This partnership aligns with the goals of BARDA DRIVe’s Beyond the Needle program: to make vaccines and therapeutics easier to administer and…
Read MoreMemphis-based US Biologic receives funding to develop orally administered flu vaccine
A Memphis-based biotech company announced in early August a partnership with a federal agency to work on a temperature stable, oral vaccine against two strains of the influenza virus. US Biologic, known for its proprietary oral-delivery platform OrisBio, produces oral vaccines and therapeutics, which are currently being used in animals to prevent zoonotic diseases. The company…
Read More